ad image

Akcea

1 / 1
Pfizer
Licensing Agreement

Akcea and Pfizer Inc. Announce Licensing Agreement for Investigative Antisense Therapy Akcea-ANGPTL3-LRX

Pfizer

PR-M10-19-NI-020Oct 11, 2019
1 / 1